BioMed Research International / 2015 / Article / Tab 5

Research Article

Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy

Table 5

Stability of CD133+ cells in physiological saline (+5% HSA) at 4°C in three ATMP-CD133 batches.

Batch #ParameterTime points
(thawing) h h h

PTC-CD133-098Viability (%)97.0091.6890.7691.07
Purity (% CD133+ cells)92.76nd92.7390.59

PTC-CD133-116Viability (%)90.7294.2394.0793.47
Purity (% CD133+ cells)84.69nd85.9885.86

Purity (% CD133+ cells)89.15nd89.4187.89

nd: not done.